02.08.2010 • NewsAir LiquideH1 2010

Air Liquide: Solid progression of Sales and Profits

Air Liquide has announced solid growth in both revenue, up 9.7%, and net profit, up 13.3% versus H1 2009. The company was able to significantly improve its operating margin: up +160 basis points at 16.6% and increase in operating cash flow by 16.7%.

Business in the first half was characterized by a solid progression of both sales and profits, as well as a recovery in growth projects. Group revenue reached €6,516 million at June 30, 2010, representing an increase of 9.7% versus H1 2009 reported sales. In Gas and Services, total sales stood at €5,695 million, up 13.4% on a reported basis, and up +9.5% on a comparable basis. After returning to growth in Q1 2010, all businesses and geographies continued to improve in Q2, with a continuing contrast between emerging economies (up 30% vs. H1 2009) and mature economies where volumes are gradually returning to their pre-crisis levels (up 6% vs. H1 2009).

Operating income recurring increased 22% to €1,084 million. The operating margin reached 16.6%, up +160 basis points vs. H1 2009, due to an increase in customer volume demand and the effectiveness of operational control measures. Net profit (Group share) was €676 million, up 13.3% versus H1 2009.

Operating cash flow was up+16.7% at €1,266 million, and net debt was stable compared to June 30, 2009. The number of investment projects has increased significantly since the beginning of the year. As a result, the portfolio of opportunities reached €4.7 billion in June.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.